Neuraly Inc.
We discover and develop revolutionary treatments for neurodegenerative diseases
Gaithersburg, United States
17 employees
Series A
Total: $36.00M
Biotechnology, Health Care
General Information
Gaithersburg, United States
BounceWatch is an independent company data service, not affiliated with Neuraly Inc.. To contact Neuraly Inc., visit neuralymed.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Neuraly Inc. compare?
A PDF of Neuraly Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Neuraly Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Neuraly Inc.
Business keywords: neurodegenerative diseases, drug development, neurology, biotech, neuroscience, clinical-stage company, glia biology, neuroinflammation, neuroprotection, PD, AD, NLY01, patents, Neuraly
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $36.00M | 9 |
|
18 Jul 2018 |
| Angel Round | Undisclosed | 1 |
|
01 Sep 2016 |
Neuraly Inc. Alternatives & Competitors
View All Alternatives
Developing a new approach to combating Alzheimer's disease and other neurodegenerative diseases.
Harnessing the power of microglia to transform treatments for neurodegenerative diseases
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
FAQ About Neuraly Inc.
Source: BounceWatch company record for Neuraly Inc., https://bouncewatch.com/company/neuraly-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.
